North America Infectious Respiratory Disease Diagnostics Market Size & Outlook
North America infectious respiratory disease diagnostics market, 2018-2030 (US$M)
Related Markets
North America infectious respiratory disease diagnostics market highlights
- The North America infectious respiratory disease diagnostics market generated a revenue of USD 22.8 million in 2024.
- The market is expected to grow at a CAGR of 4.8% from 2025 to 2030.
- In terms of segment, instruments was the largest revenue generating product in 2024.
- Instruments is the most lucrative product segment registering the fastest growth during the forecast period.
North America data book summary
| Market revenue in 2024 | USD 22.8 million |
| Market revenue in 2030 | USD 30.3 million |
| Growth rate | 4.8% (CAGR from 2024 to 2030) |
| Largest segment | Instruments |
| Fastest growing segment | Instruments |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments |
| Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Koninklijke Philips NV, BD, BioMerieux SA, Bio-Rad Laboratories Inc, QuidelOrtho Corp, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV, Roche |
Other key industry trends
- In terms of revenue, North America region accounted for 41.8% of the global infectious respiratory disease diagnostics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 16.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Infectious Respiratory Disease Diagnostics Market Scope
Infectious Respiratory Disease Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America infectious respiratory disease diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious respiratory disease diagnostics market will help companies and investors design strategic landscapes.
Instruments was the largest segment with a revenue share of 100% in 2024. Horizon Databook has segmented the North America infectious respiratory disease diagnostics market based on instruments covering the revenue growth of each sub-segment from 2018 to 2030.
North America is the largest region in the market, owing to increasing adoption of diagnostic products due to its high accuracy, sensitivity, and specificity. Increasing requirement of tests for diagnosis of diseases, such as tuberculosis, RSV, influenza A & B, and COVID-19 is expected to drive market growth.
Increasing number of strategic partnerships among manufacturers of testing kits and In Vitro Diagnostics (IVD) companies for the development of novel techniques makes North America a lucrative market for infectious respiratory disease diagnostics.
Favorable government initiatives and reimbursement policies are likely to drive market growth. The New Technology Add-on Payment (NTAP) program has been introduced by the CMS to reduce financial losses for hospitals.
Reasons to subscribe to North America infectious respiratory disease diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America infectious respiratory disease diagnostics market databook
-
Our clientele includes a mix of infectious respiratory disease diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America infectious respiratory disease diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into North America infectious respiratory disease diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America infectious respiratory disease diagnostics market
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
